168 related articles for article (PubMed ID: 24671701)
1. Acute generalized exanthematous pustulosis induced by sorafenib.
Pretel M; Iñarrairaegui M; Lera JM; Aguado L; Idoate MA
JAMA Dermatol; 2014 Jun; 150(6):664-6. PubMed ID: 24671701
[No Abstract] [Full Text] [Related]
2. Sorafenib-induced Acute Generalized Exanthematous Pustulosis: An Increasing Association?
Alegre-Sánchez A; de Perosanz-Lobo D; Pinilla-Pagnon I; Muñoz-Zato E
Actas Dermosifiliogr; 2017; 108(6):599-601. PubMed ID: 28262110
[No Abstract] [Full Text] [Related]
3. Sorafenib-induced annular pustular psoriasis (Milian-Katchoura type).
Du-Thanh A; Girard C; Pageaux GP; Guillot B; Dereure O
Eur J Dermatol; 2013; 23(6):900-1. PubMed ID: 24184416
[No Abstract] [Full Text] [Related]
4. Sorafenib-induced hand-foot syndrome.
Sioulas AD; Triantafyllou K
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):653-4. PubMed ID: 25956488
[No Abstract] [Full Text] [Related]
5. Sorafenib-induced psoriasis and hand-foot skin reaction responded dramatically to systemic narrowband ultraviolet B phototherapy.
Hung CT; Chiang CP; Wu BY
J Dermatol; 2012 Dec; 39(12):1076-7. PubMed ID: 22724918
[No Abstract] [Full Text] [Related]
6. Sorafenib: osteonecrosis of the jaw.
Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688904
[No Abstract] [Full Text] [Related]
7. A case of reversible cardiomyopathy associated with sorafenib in advanced hepatocellular carcinoma.
Park H; Han SH; Kang H; Park K
Int J Cardiol; 2012 Sep; 160(1):e10-1. PubMed ID: 22289299
[No Abstract] [Full Text] [Related]
8. Perforating folliculitis-like reaction related to sorafenib.
Eberst E; Rigau V; Pageaux GP; Guillot B; Kluger N
Cutis; 2014 Jan; 93(1):E8-10. PubMed ID: 24505595
[No Abstract] [Full Text] [Related]
9. Delayed onset perforating folliculitis associated with sorafenib.
Batalla A; Menéndez L; Blay P; Curto JR
Australas J Dermatol; 2014 Aug; 55(3):233-5. PubMed ID: 25117168
[No Abstract] [Full Text] [Related]
10. Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.
Coppola R; Zanframundo S; Rinati MV; Carbotti M; Graziano A; Galati G; De Florio L; Panasiti V
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1028-9. PubMed ID: 24628665
[No Abstract] [Full Text] [Related]
11. Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib.
Pichler M; Carriere C; Mazzoleni G; Kluge R; Eisendle K
Clin Exp Dermatol; 2014 Mar; 39(2):232-3. PubMed ID: 24330088
[No Abstract] [Full Text] [Related]
12. Small-intestinal hemorrhage caused by treatment with sorafenib for hepatocellular carcinoma and diagnosed by capsule endoscopy.
Takahashi Y; Fukunishi S; Nishikawa T; Nouda S; Sasaki Y; Sanomura M; Umegaki E; Higuchi K
Endoscopy; 2013; 45 Suppl 2 UCTN():E179-80. PubMed ID: 23801291
[No Abstract] [Full Text] [Related]
13. Sorafenib-Induced Eruption Mimicking Erythema Multiforme.
Pichard DC; Cardones AR; Chu EY; Dahut WL; Kong HH
JAMA Dermatol; 2016 Feb; 152(2):227-8. PubMed ID: 26422655
[No Abstract] [Full Text] [Related]
14. Pneumatosis intestinalis and hepatic portal venous gas in a patient receiving sorafenib.
Kashima T; Ohno Y; Tachibana M
Int J Urol; 2012 Nov; 19(11):1041-2. PubMed ID: 22788573
[No Abstract] [Full Text] [Related]
15. Bowel Perforation After Treatment with Sorafenib: A Case Report and Review of Literature.
Hamdeh S; Upadhyay S; Khanal N; Lanspa S
J Gastrointest Cancer; 2016 Dec; 47(4):420-422. PubMed ID: 26223483
[No Abstract] [Full Text] [Related]
16. Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
İlknur T; Akarsu S; Çarsanbali S; Lebe B; Fetil E
J Drugs Dermatol; 2014 Aug; 13(8):899-900. PubMed ID: 25116964
[No Abstract] [Full Text] [Related]
17. Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia.
Scott AD; Lee M; Kubba F; Chu A
Clin Exp Dermatol; 2015 Dec; 40(8):926-7. PubMed ID: 25266712
[No Abstract] [Full Text] [Related]
18. Sorafenib (NEXAVAR) and differentiated thyroid cancer. Toxic, and no proof of improved survival.
Prescrire Int; 2016 Feb; 25(168):37. PubMed ID: 27042725
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib (Nexavar) for thyroid cancer.
Med Lett Drugs Ther; 2014 May; 56(1443):43-4. PubMed ID: 24869715
[No Abstract] [Full Text] [Related]
20. Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.
Rao J; Feng M; Qian X; Li G; Wang X; Zhang F; Lu L
Hepatogastroenterology; 2013 Sep; 60(126):1317-9. PubMed ID: 23933924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]